Bamipine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y6BHZ28O92, chemically known as 4-piperidinamine, 1-methyl-n-phenyl-n-(phenylmethyl)- but generally known as bamipine, which bears US NIH Compound Identifier 72075. Bamipine most often comes in base, dihydrochloride, and hydrochloride forms. European Medicines Agency schedules Bamipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06098MIG. The term BAMIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules bamipine in its Anatomical Therapeutic Chemical (ATC) Classification. BAMIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bamipine under HS 29333999 and SITC 51574. As of Q4 2014, BAMIPINE remains the US FDA Preferred Term for this commodity. Bamipine bears US NLM identifiers UMLS ID C0052946 and NCI Concept Code C76058. SMILES: N1(CCC(N(CC2CCCCC2)C2CCCCC2)CC1)C.